Cargando…
Weight‐HbA1c‐insulin‐glucose model for describing disease progression of type 2 diabetes
A previous semi‐mechanistic model described changes in fasting serum insulin (FSI), fasting plasma glucose (FPG), and glycated hemoglobin (HbA1c) in patients with type 2 diabetic mellitus (T2DM) by modeling insulin sensitivity and β‐cell function. It was later suggested that change in body weight co...
Autores principales: | Choy, S, Kjellsson, MC, Karlsson, MO, de Winter, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728293/ https://www.ncbi.nlm.nih.gov/pubmed/26844011 http://dx.doi.org/10.1002/psp4.12051 |
Ejemplares similares
-
Comparison of Power, Prognosis, and Extrapolation Properties of Four Population Pharmacodynamic Models of HbA1c for Type 2 Diabetes
por: Wellhagen, Gustaf J., et al.
Publicado: (2018) -
Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments
por: Møller, J B, et al.
Publicado: (2013) -
Size and shape of the associations of glucose, HbA(1c), insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study
por: Ruijgrok, Carolien, et al.
Publicado: (2017) -
Simulation of a computed HbA(1c) using a weighted average glucose
por: Boutayeb, W., et al.
Publicado: (2016) -
Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)